KK
KMTS

KLP Kapitalforvaltning’s Kestra Medical Technologies KMTS Stock Holding History

KLP Kapitalforvaltning’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112K Hold
4,400
– – ﹤0.01% 2058
2026
Q1 		$87.7K Hold
4,400
– – ﹤0.01% 2078
2025
Q4 		$117K Buy
+4,400
New +$113K ﹤0.01% 2030

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

KLP Kapitalforvaltning's KMTS Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Kestra Medical Technologies (KMTS) position steady in Q2 2026 at 4,400 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #2058.

KLP Kapitalforvaltning first reported a position in KMTS in Q4 2025 and has held it in 3 quarters since. The position peaked at $117K in Q4 2025. 109 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • KLP Kapitalforvaltning held 4,400 shares of Kestra Medical Technologies worth $112K as of Q2 2026.
  • KLP Kapitalforvaltning left its Kestra Medical Technologies share count unchanged in Q2 2026.
  • Kestra Medical Technologies made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #2058 holding.
  • KLP Kapitalforvaltning first reported a position in Kestra Medical Technologies in Q4 2025 and has held it in 3 quarters since.
  • KLP Kapitalforvaltning's Kestra Medical Technologies position peaked at $117K in Q4 2025.
  • 109 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.